Tag: commercialisation
Hazer partners with US-based PSRI to fast-track commercial-scale tech deployment
Hazer Group Ltd (ASX: HZR) has announced a new partnership with US-based Particulate Solid Research, Inc (PSRI) to advance the commercial-scale rollout of its methane pyrolysis technology, strengthening its long-term strategy to deliver low-emission hydrogen at scale.
Australian biotech firm TekCyte names co-CEOs to drive global growth
Adelaide-based biotechnology company TekCyte Limited has appointed a new co-CEO leadership team as it prepares to expand its global footprint.
Hazer secures $2M funding to advance graphite commercialisation efforts
Hazer Group Ltd has announced it has secured more than $2 million in funding to support the next stage of its graphite commercialisation strategy, strengthening its collaboration with the University of Sydney under the Australian Research Council (ARC) Industry Fellowship scheme.
Ops milestone unlocks $500K for Hazer Group under ARENA deal
Hazer Group Limited has achieved a key milestone under its funding agreement with the Australian Renewable Energy Agency (ARENA), enabling the company to draw down $500,000 in funding.
Atmo Biosciences secures full ownership of gas-sensing capsule from RMIT
An ingestible gas-sensing capsule developed at RMIT University has moved closer to commercialisation, with the university transferring intellectual property (IP) to Atmo Biosciences in exchange for an equity stake in the company.
Call for R&D reform as productivity stagnates, says Ai Group
The Australian Industry Group (Ai Group) has called for a significant overhaul of the country’s research and development (R&D) system, warning that Australia risks falling behind if commercialisation and productivity outcomes are not prioritised in future reforms.
IDT Australia secures $3.2M manufacturing contract for investigational eye therapy
ASX-listed IDT Australia Limited has been awarded a five-year contract valued at $3.2 million for the manufacture of NPI-001 tablets, an investigational treatment for retinitis pigmentosa (RP), a degenerative eye disease that can lead to vision loss.
Swinburne and H3D partner to revolutionise dental manufacturing with AI
Swinburne University of Technology has announced an investment in H3D, a technology company focused on AI-driven design for dental devices.
WOA secures new international sales for lupin protein isolates
Wide Open Agriculture has secured new sales across Europe, Latin America, and Australia as part of its ongoing efforts to commercialise its lupin protein isolates.
Hazer’s reactor testing in Canada validates commercial design
Hazer Group has announced the completion of a commercial reactor test program in Canada, marking a key milestone in its partnership with FortisBC Energy Inc.
Featured Article
Unlocking growth: Charting midsize manufacturers’ path with digital solutions
According to a recent study by Oxford Economics, midsized companies in the industrial manufacturing sector are setting their eyes on ambitious growth targets. The research, authored in partnership with SAP, revealed that 38% of industry leaders have identified market expansion as their top priority.
